Rhett blood glucose monitoring system
Taiwan·Risk Class 2·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered Jul 17, 2018 – Jul 17, 2028Active- Analysis ID
- 278e256cfad7265804ade0b4bdccb9a1
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
- Intended Use
- This product is for in vitro diagnostic use, intended for general personnel (self-test and professional use), to measure fresh whole blood glucose obtained through fingertips, palms or microvessels of the arm, not suitable for newborns.
- Product Type (Level 1)
- A Clinical Chemistry and Clinical Toxicology;; I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); I.4800 Surgical Hand Instruments for General Surgery;; A.1345 Glucose test system
- Import Information
- Domestic
- Registration Date
- Jul 17, 2018
- Expiry Date
- Jul 17, 2028
Top companies providing products similar to "Rhett blood glucose monitoring system"
Recently registered similar products
Access comprehensive regulatory information for Rhett blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 278e256cfad7265804ade0b4bdccb9a1 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Daqing Factory of Huaguang Biotechnology Co., Ltd, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.